Tenet Healthcare (NYSE:THC) Releases Earnings Results, Beats Expectations By $0.49 EPS

Tenet Healthcare (NYSE:THC) posted its quarterly earnings results on Wednesday. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49, Zacks reports. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. Tenet Healthcare updated its FY 2025 guidance to 11.740-12.840 EPS.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock traded down $8.73 during midday trading on Wednesday, hitting $130.10. The company had a trading volume of 1,647,157 shares, compared to its average volume of 1,064,176. The business’s 50 day simple moving average is $133.85 and its two-hundred day simple moving average is $148.52. The stock has a market cap of $12.37 billion, a PE ratio of 4.17, a P/E/G ratio of 0.63 and a beta of 2.05. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52. Tenet Healthcare has a 1-year low of $86.90 and a 1-year high of $171.20.

Wall Street Analysts Forecast Growth

THC has been the subject of several research reports. KeyCorp decreased their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Barclays boosted their price target on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an “overweight” rating in a report on Friday, November 8th. Wells Fargo & Company cut Tenet Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $205.00 to $150.00 in a research report on Monday, November 25th. Royal Bank of Canada lifted their price target on Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Raymond James lowered shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a research report on Friday, November 22nd. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $165.00.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.